Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention - Cureus

Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention  CureusWeight-loss drugs could prevent fatal complications from heart attacks, UK study finds  The GuardianDiabetes: GLP-1s and Healthy Lifestyle Help Lower Cardiovascular Risk  HealthlineHow do weight loss medications interact with the heart?  WGN Radio 720GLP-1s and Immune Modulation: Exploring Anti-Inflammatory Potential  Diabetes In Control